1. M. Lohoff, S. Prechtl, F. Sommer, M. Roellinghoff, E. Schmitt, G. Gradehandt, P. Rohwer, B.D. Stride, S.P.C. Cole and R.G. Deeley. A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th) 2, but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo. J. Clin. Invest. 101: 703-710 (1998).
  2. M. Gao, M. Yamazaki, D.W. Loe, C.J. Westlake, C.E. Grant, S.P.C. Cole and R.G. Deeley. Multidrug Resistance Protein: Identification of regions required for active transport of leukotriene C4. J. Biol. Chem. 273: 10733-10740 (1998).
  3. D.R. Hipfner, M. Gao, G. Scheffer, R.J. Scheper, R.G. Deeley and S.P.C. Cole. Epitope mapping of monoclonal antibodies specific for the 190 kDa Multidrug Resistance Protein, MRP. Br. J. Cancer 78: 1134-1140 (1998).
  4. C.E. Grant, G. Bhardwaj, S.P.C. Cole and R.G. Deeley. Cloning, transfer and characterizaton of MRP. Meth. Enzymol. 292: 594-607 (1998). (invited).
  5. Y. Canitrot, F. Bichat, S. Cole, R. Deeley, J. Gerlach, G. Bastian, F. Arvelo and M. Poupon. Expression of the multidrug resistance genes (MRP) and (MDR1) in small cell lung cancer xenografts: relationship with clinical outcome. Cancer Lett. 130: 133-141 (1998).
  6. S.P.C. Cole and R.G. Deeley. Multidrug resistance mediated by the ATP-binding cassette transporter protein, MRP. BioEssays 20: 931-940 (1998) (Invited, peer-reviewed)
  7. S.R. Wright, A.H. Boag, B.G. Campling, G. Valdimarsson, D.R. Hipfner, S.P.C. Cole and R.G. Deeley. Immunohistochemical detection of Multidrug Resistance Protein (MRP) in human lung cancer and normal lung. Clin. Cancer Res. 4: 2279-2289 (1998).
  8. D.W. Loe, R.G. Deeley and S.P.C. Cole. Characterization of vincristine transport by the 190 kDa Multidrug Resistance Protein, MRP: Evidence for co-transport with reduced glutathione. Cancer Res. 58: 5130-5136 (1998).
  9. A.J. Lang, S.E.L. Mirski, H.J. Cummings, Q. Yu, J.H. Gerlach and S.P.C. Cole. Structural organization of the human TOP2A and TOP2B genes. Gene 221: 255-266 (1998).
  10. T. Abe, T. Mori, Y. Wakabayashi, M. Nakagawa, S.P.C. Cole, K. Koike, M. Kuwano and S. Hori. Expression of multidrug resistance protein gene in patients with glioma after chemotherapy. J. Neuro-Oncol. 40: 11-18 (1998).
  11. B. Savas, P.E. Kerr, H. Ustun, S.P.C. Cole and H.F. Pross. Lymphokine-activated killer cell susceptibility and multidrug resistance in small cell lung carcinoma. Anticancer Res. 18: 4355-4361 (1998).